Laekna, Inc.
PublicLaekna, Inc. is now publicly traded
The data on this page reflects Laekna, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jun 29, 2023
Last Round
Private Placement
Sep 24, 2025
Total Funding Raised
$344.31M
Company Overview
Laekna, Inc. operates in Biotech and is based in Shanghai, Shanghai. Its recorded funding history includes a Series D round in May 2022.
Laekna, Inc. is a clinical-stage biotechnology company that discovers and develops innovative therapies for cancer, metabolic diseases, and liver fibrosis.
Sector
Biotech
AI Layer
Non-AI
Laekna, Inc. Comparables
Compare Laekna, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Promontory Therapeutics | 61% |
For institutional investors. Book with your work email.
Laekna, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Sep 24, 2025 | ||||
| IPO | Jun 29, 2023 | ||||
| Series D | May 18, 2022 | ||||
| Series C | Oct 1, 2020 | ||||
| Series B | Apr 2, 2019 | ||||
Series A | Jun 4, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Laekna, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed Asia | Series B, Series A |
| Yanchuang Capital | Series D |
| CS Capital | IPO, Series C, Series D |
| Ningbo Yaoshang Yanchuang Chenkai Venture Capital Partnership (Limited Partnership) | IPO |
| SDIC Innovation Investment Management | IPO |
| OrbiMed | Series B, Series A, IPO |
| Infinity Capital | Series D |
For institutional investors. Book with your work email.
Laekna, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.